ALTAIRE PHARMS INC
GenericsALTAIRE PHARMS INC is a generic drug manufacturer focused on Infectious Disease, Dermatology, Immunology. Key products include ALTAFLUOR BENOX.
ALTAIRE PHARMS INC's Key Drugs
ALTAIRE PHARMS INC's core commercial portfolio centers on ALTAFLUOR BENOX, spanning Infectious Disease and Dermatology — its most strategically important drugs approved in the last 15 years.
ALTAIRE PHARMS INC's Recent FDA Approvals
New NDA/BLA approvals for ALTAIRE PHARMS INC over the last two years — novel drugs only, excluding generics and label supplements.
ALTAIRE PHARMS INC's Therapeutic Areas
ALTAIRE PHARMS INC's approved drugs and pipeline span 3 therapeutic areas, led by Infectious Disease and Dermatology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ALTAIRE PHARMS INC's Top Competitors
ALTAIRE PHARMS INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, BAUSCH AND LOMB INC, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ALTAIRE PHARMS INC Pipeline Snapshot
Active clinical trials for ALTAIRE PHARMS INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • ALTAFLUOR BENOX leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2010-09-27
- Latest
- 2018-05-03
- Applications
- 5